Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
, , , , , y
28 sept 2019
Acerca de este artículo
Publicado en línea: 28 sept 2019
Páginas: 154 - 159
Recibido: 08 ene 2019
Aceptado: 27 mar 2019
DOI: https://doi.org/10.2478/cipms-2019-0028
Palabras clave
© 2019 Roman Yarema et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Yarema, Roman
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Volodko, Nataliya
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Fetsych, Taras
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Оhorchak, Myron
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Petronchak, Orest
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Mylyan, Yuriy
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Makukh, Halyna
SI “Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences”Lviv, Ukraine